Target intelligence / Profile preview

Wolbachia 50S ribosomal subunit (None commonly used; in literature, may appear as "Wolbachia 50S" or simply "50S subunit")

Target
None commonly used; in literature, may appear as "Wolbachia 50S" or simply "50S subunit"
Molecular classification
Ribosome, Ribonucleoprotein complex, Enzyme (peptidyl transferase activity), Translation machinery
01

Overview

The Wolbachia 50S ribosomal subunit is the large subunit of the bacterial ribosome, composed of 23S and 5S ribosomal RNAs and approximately 31 distinct proteins. It functions as the catalytic core for peptide bond formation during protein synthesis. This subunit is essential for bacterial viability and is broadly conserved among prokaryotes. In Wolbachia, as in other bacteria, the 50S subunit is crucial for translation and is the molecular target for several antibiotic classes—including macrolides, lincosamides, and phenicols—making it a validated therapeutic target for treating Wolbachia-associated infections and for anti-filarial strategies. Structural differences in the binding pockets between bacterial and eukaryotic ribosomes allow for selective inhibition by antibacterial drugs.

Other names
Wolbachia large ribosomal subunitWolbachia 50SBacterial 50S ribosomal subunit (general)Prokaryotic 50S ribosomal subunit
02

Mechanism of action

Inhibition of peptide bond formation; Blockage of ribosomal translocation; Inhibition of tRNA binding; Prevention of ribosome assembly and maturation

03

Biological functions

Protein synthesis (translation)Peptidyl transferase activity (catalyzes peptide bond formation)Antibiotic binding site
04

Disease associations

Infection (target for anti-Wolbachia therapy in filarial diseases and potentially in vector control)
05

Safety considerations

Host toxicity: Human ribosomes are structurally distinct (60S/40S subunits), but off-target effects at high antibiotic concentrations or with improperly selective agents may occur.Resistance development: Mutations in 50S rRNA or ribosomal proteins can lead to antibiotic resistance, limiting therapeutic success
06

Interacting drugs

Macrolide antibiotics (e.g., erythromycin, azithromycin)

5 more in the full profile.

07

Biomarkers

Presence of Wolbachia-specific ribosomal RNA (23S rRNA, 5S rRNA; detection of Wolbachia infection)Antibiotic susceptibility testing (phenotypic response to 50S-targeting agents)

Beyond the preview

Go deeper on Wolbachia 50S ribosomal subunit (None commonly used; in literature, may appear as "Wolbachia 50S" or simply "50S subunit").

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wolbachia 50S ribosomal subunit (None commonly used; in literature, may appear as "Wolbachia 50S" or simply "50S subunit").

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call